INVESTOR RELATIONS
Join the New Wave of Ultrasound Technology
Use of MRI for the routine diagnosis of musculoskeletal
conditions in the U.S. will cost $2.5 billion by 2020.
Echometrix’s advancement of
ultrasound technology for the evaluation
of musculoskeletal conditions will help to
solve this problem by making ultrasound
easier to use by the treating clinician.
Workers, soldiers and athletes will all
benefit from a more available and more
objective evaluation at initial diagnosis
and during rehabilitation
Our opportunity is well timed because
ultrasound equipment miniaturization,
cost reduction and improvements
in image quality have dramatically
expanded the useful applications for
ultrasound in healthcare. One of the least
penetrated markets for ultrasound is
musculoskeletal, and major players in
the ultrasound industry are very focused
on this market.
Echometrix is a Wisconsin Qualified New Business Venture - qualified and in-state investors receive a 25% tax credit from the State of Wisconsin.
If you are interested in an investment opportunity with Echometrix,
contact Echometrix at admin@echo-metrix.com
or call 608.217.2685
